Patents by Inventor Tanya Goncharov

Tanya Goncharov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7799901
    Abstract: The present invention provides proteins capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 protein, which in turn binds to the intracellular domain of the FAS receptor or to another protein TRADD which binds to the p55 receptor. In addition, peptide inhibitors that interfere with the proteolytic activity of MORT-1-binding proteins having proteolytic activity are provided, as well as a method of designing them.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: September 21, 2010
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Mark Boldin, Tanya Goncharov, Yury V. Golstev
  • Publication number: 20080139476
    Abstract: There are provided polypeptides which bind to caspase-8. Production and use of such polypeptides is also provided, as well as DNA encoding them, and vectors and host cells having such DNA.
    Type: Application
    Filed: January 8, 2008
    Publication date: June 12, 2008
    Applicant: Yeda Research and Development Company Ltd.
    Inventors: David WALLACH, Marcus Schuchmann, Tanya Goncharov
  • Patent number: 7339047
    Abstract: There are provided polypeptides which bind to caspase-8. Production and use of such polypeptides is also provided, as well as DNA encoding them, and vectors and host cells having such DNA.
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: March 4, 2008
    Assignee: Yeda Research and Development Company Ltd.
    Inventors: David Wallach, Marcus Schuchmann, Tanya Goncharov
  • Publication number: 20070166787
    Abstract: A modulator of regulatory cellular events occurring intracellularly which are mediated by regulatory proteins containing a ‘death domain’ motif is provided. The ‘death domain’ is a regulatory portion of the regulatory proteins, and the modulator is capable of interacting with one or more ‘death domain’ motifs contained in the regulatory proteins and affecting the regulatory action of one or more of the regulatory proteins. The modulator preferably is capable of interacting with ‘death domain’ motifs within p55-TNF-R, FAS/APO1-R, NGF-R, MORT-1, RIP, TRADD, or ankyrin. A method for producing the modulators is also provided. The modulators are useful for modulating functions mediated in cells by proteins containing the ‘death domain’.
    Type: Application
    Filed: August 29, 2006
    Publication date: July 19, 2007
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Mark Boldin, Eugene Varfolomeev, Zeev Pancer, Igor Mett, Tanya Goncharov
  • Publication number: 20070154905
    Abstract: The present invention provides proteins capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 protein, which in turn binds to the intracellular domain of the FAS receptor or to another protein TRADD which binds to the p55 receptor. In addition, peptide inhibitors that interfere with the proteolytic activity of MORT-1-binding proteins having proteolytic activity are provided, as well as a method of designing them.
    Type: Application
    Filed: September 18, 2006
    Publication date: July 5, 2007
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Mark Boldin, Tanya Goncharov, Yury Golstev
  • Publication number: 20040229260
    Abstract: There are provided polypeptides which bind to caspase-8. Production and use of such polypeptides is also provided, as well as DNA encoding them, and vectors and host cells having such DNA.
    Type: Application
    Filed: April 1, 2004
    Publication date: November 18, 2004
    Applicant: Yeda Research and Development Company Ltd
    Inventors: David Wallach, Marcus Schuchmann, Tanya Goncharov
  • Patent number: 6762283
    Abstract: There are provided proteins which interact with caspase-8. Production and use of such proteins is also provided.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: July 13, 2004
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Marcus Schuchmann, Tanya Goncharov
  • Publication number: 20030219411
    Abstract: The present invention provides proteins capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 protein, which in turn binds to the intracellular domain of the FAS receptor or to another protein TRADD which binds to the p55 receptor. In addition, peptide inhibitors that interfere with the proteolytic activity of MORT-1-binding proteins having proteolytic activity are provided, as well as a method of designing them.
    Type: Application
    Filed: February 20, 2003
    Publication date: November 27, 2003
    Applicant: Yeda Research and Development Co., LTD
    Inventors: David Wallach, Mark Boldin, Tanya Goncharov, Yury V. Golstev
  • Patent number: 6586571
    Abstract: The present invention provides proteins capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 protein, which in turn binds to the intracellular domain of the FAS receptor or to another protein TRADD which binds to the p55 receptor. In addition, peptide inhibitors which interfere with the proteolytic activity of MORT-1-biding proteins having proteolytic activity are provided as well as a method of designing them.
    Type: Grant
    Filed: March 1, 2000
    Date of Patent: July 1, 2003
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Mark Boldin, Tanya Goncharov, Yury V. Golstev
  • Patent number: 6399327
    Abstract: The present invention provides proteins capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 protein, which in turn binds to the intracellular domain of the FAS receptor or to another protein TRADD which binds to the p55 receptor. In addition, peptide inhibitors which interfere with the proteolytic activity of MORT-1-biding proteins having proteolytic activity are provided as well as a method of designing them.
    Type: Grant
    Filed: April 10, 1998
    Date of Patent: June 4, 2002
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Mark Boldin, Tanya Goncharov, Yury V. Golstev